MAZE
Maze Therapeutics·NASDAQ
--
--(--)
--
--(--)
MAZE fundamentals
Maze Therapeutics (MAZE) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), missed estimates; EPS was -0.77 (YoY --), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.77
--
Report date
Aug 12, 2025
EPS
Actual | -18.32 | -0.77 |
Forecast | 2.05 | -0.836 |
Surprise | -993.66% | +7.89% |
Revenue
Actual | 0 | 0 |
Forecast | 0 | 3.13M |
Surprise | 0.00% | -100.00% |
Earnings Call
You can ask Aime
What were the key takeaways from Maze Therapeutics’s earnings call?What is Maze Therapeutics's latest dividend and current dividend yield?What does Maze Therapeutics do and what are its main business segments?What factors drove the changes in Maze Therapeutics's revenue and profit?What guidance did Maze Therapeutics's management provide for the next earnings period?What is the market's earnings forecast for Maze Therapeutics next quarter?Did Maze Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Maze Therapeutics's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
